Literature DB >> 26643891

Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 (CIP1/WAF1) expression.

Chenghe Wang1,2, Qiangqiang Ge1, Zhong Chen3, Jia Hu1, Fan Li1, Zhangqun Ye1.   

Abstract

Accumulating data suggest that micro RNAs (miRNAs) or double-stranded RNAs (dsRNAs) can activate gene expression by targeting promoters. The cyclin-dependent kinase inhibitor p21 (CIP1/WAF1) (p21) has also been shown to suppress epithelial-mesenchymal transition (EMT) which plays a crucial role in the early stage of tumor metastases and invasiveness. In a previous study, we have reported that miR-370-5p is low-expressed in bladder cancer (BCa) tissues and cell lines. Here, we identified that miR-370-5p and sequence homology dsRNA (dsP21-555) fully complementary to promoter hold the potent abilities to induce p21 expression. Moreover, transfection of miR-370-5p or dsP21-555 into BCa cells remarkably inverts EMT-associated genes (increases epithelial cell makers E-cadherin and β-catenin, and decreases mesenchymal cell markers ZEB1 and Vimentin) expression mainly via regulating p21 expression. Besides, through manipulating p21, both the candidates can retard BCa cell migration and invasion. In summary, our results provide evidence that both endogenous and exogenous small RNAs may function to induce p21 expression by interacting with the similar promoter region and impede BCa metastasis.

Entities:  

Keywords:  Bladder cancer; Double-stranded RNA; Epithelial-mesenchymal transition; Micro RNA; RNA activation; p21

Mesh:

Substances:

Year:  2015        PMID: 26643891     DOI: 10.1007/s13277-015-4571-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  35 in total

Review 1.  MicroRNAs--targeting and target prediction.

Authors:  Takaya Saito; Pal Saetrom
Journal:  N Biotechnol       Date:  2010-02-26       Impact factor: 5.079

Review 2.  Small RNA and transcriptional upregulation.

Authors:  Victoria Portnoy; Vera Huang; Robert F Place; Long-Cheng Li
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-05-02       Impact factor: 9.957

Review 3.  Epidemiology and risk factors of urothelial bladder cancer.

Authors:  Maximilian Burger; James W F Catto; Guido Dalbagni; H Barton Grossman; Harry Herr; Pierre Karakiewicz; Wassim Kassouf; Lambertus A Kiemeney; Carlo La Vecchia; Shahrokh Shariat; Yair Lotan
Journal:  Eur Urol       Date:  2012-07-25       Impact factor: 20.096

4.  Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.

Authors:  Kun Tang; Chenghe Wang; Zhong Chen; Hua Xu; Zhangqun Ye
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

5.  Double strand RNA-guided endogeneous E-cadherin up-regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo.

Authors:  Wei Junxia; Gao Ping; Han Yuan; Zhang Lijun; Ren Jihong; Lin Fang; Long Min; Wang Xi; He Ting; Dong Ke; Zhang Huizhong
Journal:  Cancer Sci       Date:  2010-04-21       Impact factor: 6.716

6.  Defining features and exploring chemical modifications to manipulate RNAa activity.

Authors:  Robert F Place; Emily J Noonan; Zeno Földes-Papp; Long-Cheng Li
Journal:  Curr Pharm Biotechnol       Date:  2010-08       Impact factor: 2.837

7.  Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy.

Authors:  Mikko P Turunen; Tiia Lehtola; Suvi E Heinonen; Genet S Assefa; Petra Korpisalo; Roseanne Girnary; Christopher K Glass; Sami Väisänen; Seppo Ylä-Herttuala
Journal:  Circ Res       Date:  2009-08-20       Impact factor: 17.367

8.  p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo.

Authors:  Manran Liu; Mathew C Casimiro; Chenguang Wang; L Andrew Shirley; Xuanmao Jiao; Sanjay Katiyar; Xiaoming Ju; Zhiping Li; Zuoren Yu; Jie Zhou; Michael Johnson; Paolo Fortina; Terry Hyslop; Jolene J Windle; Richard G Pestell
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-26       Impact factor: 11.205

Review 9.  Prognostic markers in muscle invasive bladder cancer.

Authors:  Rabi Tiguert; Annie Lessard; Alan So; Yves Fradet
Journal:  World J Urol       Date:  2002-06-07       Impact factor: 4.226

Review 10.  Bladder cancer.

Authors:  Donald S Kaufman; William U Shipley; Adam S Feldman
Journal:  Lancet       Date:  2009-06-10       Impact factor: 79.321

View more
  8 in total

1.  Regulation of SLD5 gene expression by miR-370 during acute growth of cancer cells.

Authors:  Keitaro Yamane; Hisamichi Naito; Taku Wakabayashi; Hironori Yoshida; Fumitaka Muramatsu; Tomohiro Iba; Hiroyasu Kidoya; Nobuyuki Takakura
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

2.  HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372.

Authors:  Jiahui An; Jie Xu; Jiao Li; Song Jia; Xiaonan Li; Yanan Lu; Yuxin Yang; Zhuojia Lin; Xiaoru Xin; Mengying Wu; Qidi Zheng; Hu Pu; Xin Gui; Tianming Li; Dongdong Lu
Journal:  Oncotarget       Date:  2017-07-25

3.  miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.

Authors:  Zhuojia Lin; Yanan Lu; Qiuyu Meng; Chen Wang; Xiaonan Li; Yuxin Yang; Xiaoru Xin; Qidi Zheng; Jie Xu; Xin Gui; Tianming Li; Hu Pu; Wujun Xiong; Jiao Li; Song Jia; Dongdong Lu
Journal:  Mol Ther Nucleic Acids       Date:  2018-04-12       Impact factor: 8.886

4.  MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21.

Authors:  Qingsong Zhang; Shuo Miao; Xihong Han; Chuanchang Li; Mengyang Zhang; Kai Cui; Tao Xiong; Zhong Chen; Chenghe Wang; Hua Xu
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

5.  Integrative analysis of single-cell expression data reveals distinct regulatory states in bidirectional promoters.

Authors:  Fatemeh Behjati Ardakani; Kathrin Kattler; Karl Nordström; Nina Gasparoni; Gilles Gasparoni; Sarah Fuchs; Anupam Sinha; Matthias Barann; Peter Ebert; Jonas Fischer; Barbara Hutter; Gideon Zipprich; Charles D Imbusch; Bärbel Felder; Jürgen Eils; Benedikt Brors; Thomas Lengauer; Thomas Manke; Philip Rosenstiel; Jörn Walter; Marcel H Schulz
Journal:  Epigenetics Chromatin       Date:  2018-11-10       Impact factor: 4.954

6.  MicroRNA-370 inhibits the growth and metastasis of lung cancer by down-regulating epidermal growth factor receptor expression.

Authors:  Xin Liu; You-Guang Huang; Cong-Guo Jin; Yong-Chun Zhou; Xiao-Qun Chen; Jia Li; Yan Chen; Mei Li; Qian Yao; Ke Li; Min Lan; Jia-Gui Ye; Xi-Cai Wang
Journal:  Oncotarget       Date:  2017-10-04

7.  Enhancing E-cadherin expression via promoter-targeted miR-373 suppresses bladder cancer cells growth and metastasis.

Authors:  Qingsong Zhang; Chenghe Wang; Shuo Miao; Chuanchang Li; Zhong Chen; Fan Li
Journal:  Oncotarget       Date:  2017-09-30

8.  lncRNA BCAR4 sponges miR‑370‑3p to promote bladder cancer progression via Wnt signaling.

Authors:  Rongkui Zhang; Jiping Wang; Er'na Jia; Jialiang Zhang; Nan Liu; Changliang Chi
Journal:  Int J Mol Med       Date:  2019-12-27       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.